Carolyn D. Runowicz, MD is Professor of Obstetrics and Gynecology and Executive Associate Dean for Academic Affairs at Herbert Wertheim College of Medicine Florida International University at Miami, Florida. Dr. Runowicz is a nationally and internationally recognized leader in women's health and gynecologic cancer. Her research has focused on the development, initiation and conduct of clinical trials in gynecologic cancer and in cancer prevention. She has authored more than 200 scientific articles and 5 books. She has received numerous honors and awards, including the 2018 Distinguished Service Award by the Society of Gynecologic Oncology. This honor recognizes individuals who, over an extended period of time, display a continuous outstanding meritorious service in the field of gynecologic oncology. She is also the recipient of the University of Connecticut Distinguished Alumni Award, the American Medical Women's Association Local Legend Award, Cancer Care Physician of the Year Award, and many others. She serves as a role model and mentor for faculty and students.
She has served in leadership roles in the major cancer organizations. She served as the first woman president of the Society of Gynecologic Oncologists (2000), was President of the American Cancer Society (2005) and served on the National Cancer Advisory Board (NCAB), appointed by President George W. Bush. She served as Chair of the NCAB for 4 years (2006-2010). She served on the Board of Directors of the American Society of Clinical Oncology (2011-2015) as the first gynecologic oncologist. She completed 2 terms as Vice President of the American Gynecological and Obstetrical Foundation Board.
She has served on numerous committees for the Society of Gynecologic Oncology, American College of Obstetricians and Gynecologists, American Cancer Society, the National Cancer Institute, the National Surgical Adjuvant Breast and Bowel Project, the American Society of Clinical Oncology and the American Gynecologic and Obstetrical Society. She is a reviewer for several medical journals and has served on editorial boards in recognition of her expertise in women's health and gynecologic cancers. She is on several scientific advisory boards and expert review panels, including the National Cancer Institute and the Ovarian Cancer Research Foundation.
She is an expert in gynecologic oncology, specifically ovarian cancer. She has initiated and led many innovative clinical trials in the development of novel therapies for gynecologic cancers. Her current research, in collaboration with an investigator at the University of Miami College of Engineering, is evaluating a novel treatment for ovarian cancer using magneto-electric nanoparticles and externally applied magnetic fields.